Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Hyper-responsiveness to stimulation of human immunodeficiency virus-infected CD4+ T cells requires Nef and Tat virus gene products and results from higher NFAT, NF-kappaB, and AP-1 induction.
Fortin JF, Barat C, Beauséjour Y, Barbeau B, Tremblay MJ.
J Biol Chem. 2004 Sep 17;279(38):39520-31. Epub 2004 Jul 16. Erratum in: J Biol Chem. 2005 Mar 11;280(10):9752.
Related citations
HIV Tat activates c-Jun amino-terminal kinase through an oxidant-dependent mechanism.
Gu Y, Wu RF, Xu YC, Flores SC, Terada LS.
Virology. 2001 Jul 20;286(1):62-71.
Extracellular Tat activates c-fos promoter in low serum-starved CD4+ T cells.
Gibellini D, Re MC, Ponti C, Celeghini C, Melloni E, La Placa M, Zauli G.
Br J Haematol. 2001 Mar;112(3):663-70.
Differential requirement for p56lck in HIV-tat versus TNF-induced cellular responses: effects on NF-kappa B, activator protein-1, c-Jun N-terminal kinase, and apoptosis.
Manna SK, Aggarwal BB.
J Immunol. 2000 May 15;164(10):5156-66.
Extracellular HIV-1 Tat protein differentially activates the JNK and ERK/MAPK pathways in CD4 T cells.
Mischiati C, Pironi F, Milani D, Giacca M, Mirandola P, Capitani S, Zauli G.
AIDS. 1999 Sep 10;13(13):1637-45.
HIV-Tat protein activates c-Jun N-terminal kinase and activator protein-1.
Kumar A, Manna SK, Dhawan S, Aggarwal BB.
J Immunol. 1998 Jul 15;161(2):776-81.
Human immunodeficiency virus tat modulates the Flk-1/KDR receptor, mitogen-activated protein kinases, and components of focal adhesion in Kaposi's sarcoma cells.
Ganju RK, Munshi N, Nair BC, Liu ZY, Gill P, Groopman JE.
J Virol. 1998 Jul;72(7):6131-7.
Tat protein induces self-perpetuating permissivity for productive HIV-1 infection.
Li CJ, Ueda Y, Shi B, Borodyansky L, Huang L, Li YZ, Pardee AB.
Proc Natl Acad Sci U S A. 1997 Jul 22;94(15):8116-20.
An RGD containing peptide from HIV-1 Tat-(65-80) modulates protooncogene expression in human bronchoalveolar carcinoma cell line, A549.
el-Solh A, Kumar NM, Nair MP, Schwartz SA, Lwebuga-Mukasa JS.
Immunol Invest. 1997 Apr;26(3):351-70.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on